We now have Quarter 4 H1B visa FY 2023 data and Quarter 4 PERM visa FY 2023 data and Quarter 4 H2A visa FY 2023 data.
Employer Search tool is moved to it's own page: "H1B Visa Data Search Tool"

Statistics and Summary

Dennis Hul has been assisting clients through the H1B Visa process since 2020.

As of 2022, Dennis Hul has succesfully submitted and recieved certification for 764 cases.

Dennis Hul is located in New York, NY, and has represented 13 employers for the H1B Visa Process

772
Cases Handled
764
Cases Certified
98.96%
Approval

Cases Handled by Dennis Hul

Case Number Case Status Job Title Industry Name Employer Name Year
I-200-21067-127220 Certified Biochemists And Biophysicists Pharmaceutical Preparation Manufacturing Boehringer Ingelheim Pharmaceuticals Inc 2021
I-200-21066-126690 Certified Biochemists And Biophysicists Pharmaceutical Preparation Manufacturing Boehringer Ingelheim Pharmaceuticals Inc 2021
I-200-21065-125945 Certified Biochemists And Biophysicists Pharmaceutical Preparation Manufacturing Boehringer Ingelheim Pharmaceuticals Inc 2021
I-200-21063-119696 Certified Biochemists And Biophysicists Pharmaceutical Preparation Manufacturing Boehringer Ingelheim Pharmaceuticals Inc 2021
I-200-21063-119569 Certified Biochemists And Biophysicists Pharmaceutical Preparation Manufacturing Boehringer Ingelheim Pharmaceuticals Inc 2021
I-200-21063-119509 Certified Biochemists And Biophysicists Pharmaceutical Preparation Manufacturing Boehringer Ingelheim Pharmaceuticals Inc 2021
I-200-21063-119470 Certified Biochemists And Biophysicists Pharmaceutical Preparation Manufacturing Boehringer Ingelheim Pharmaceuticals Inc 2021
I-200-21063-118542 Certified Biochemists And Biophysicists Pharmaceutical Preparation Manufacturing Boehringer Ingelheim Usa Corporation 2021
I-200-21063-118489 Certified Biochemists And Biophysicists Pharmaceutical Preparation Manufacturing Boehringer Ingelheim Usa Corporation 2021
I-200-21061-113071 Certified Biochemists And Biophysicists Pharmaceutical Preparation Manufacturing Boehringer Ingelheim Pharmaceuticals Inc 2021